Evaluation of the radioprotective effect of Liv 52 in mice

Ganesh C. Jagetia, Narsipura G. Ganapathi, Ponemone Venkatesh, Nageshwar Rao, Manjeshwar S. Baliga

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Liv 52 is a mixture of botanicals that is used clinically to treat various hepatic disorders. In this study, the radioprotective activity of Liv 52 was evaluated in mice given whole-body exposure to different doses of γ-radiation. In addition, a series of studies was conducted to explore the mechanism of radioprotection. Radioprotection was evaluated by the ability of Liv 52 to reduce both the frequency of bone marrow micronucleated erythrocytes and the lethality produced by 60Co γ-radiation. Mice were treated by oral gavage once daily for seven consecutive days with 500 mg/kg body weight Liv 52 or carboxymethylcellulose vehicle prior to radiation. Micronucleated polychromatic erythrocytes (MPCEs), micronucleated normochromatic erythrocytes (MNCEs), and the PCE/NCE ratio were measured at 0.25-14 days after exposure to whole-body radiation doses of 0, 0.5, 1.5, 3.0, or 4.5 Gy; animal survival was monitored after doses of 7, 8, 9, 10, 11, or 1 2 Gy. Pretreatment of mice with Liv 52 significantly reduced the frequency of radiation-induced MPCEs and MNCEs. Irradiation reduced the PCE/NCE ratio in a dose-related manner for up to 7 days following irradiation; Liv 52 pretreatment significantly mitigated against these reductions. Liv 52 treatment also reduced the symptoms of radiation sickness and increased mouse survival 10 and 30 days after irradiation. Liv 52 pretreatment elevated the levels of reduced glutathione (GSH), increased the activities of glutathione transferase, GSH peroxidase, GSH reductase, superoxide dismutase, and catalase, and lowered lipid peroxidation (LPx) and the activities of alanine aminotransferase and aspartate aminotransferase 30 min after exposure to 7 Gy of γ-radiation. Liv 52 pretreatment also reduced radiation-induced LPx and increased GSH concentration 31 days following the exposure. The results of this study indicate that pretreatment with Liv 52 reduces the genotoxic and lethal effects of γ-irradiation in mice and suggest that this radioprotection may be afforded by reducing the toxic effects of the oxidative products of irradiation.

Original languageEnglish
Pages (from-to)490-502
Number of pages13
JournalEnvironmental and Molecular Mutagenesis
Volume47
Issue number7
DOIs
Publication statusPublished - 01-08-2006
Externally publishedYes

Fingerprint

Erythrocytes
Radiation
Lipid Peroxidation
Liv 52
Radiation Dosage
Radiation Injuries
Carboxymethylcellulose Sodium
Whole-Body Irradiation
Poisons
Aspartate Aminotransferases
Glutathione Transferase
Alanine Transaminase
Catalase
Peroxidase
Superoxide Dismutase
Glutathione
Oxidoreductases
Bone Marrow
Body Weight
Liver

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Genetics(clinical)
  • Health, Toxicology and Mutagenesis

Cite this

Jagetia, G. C., Ganapathi, N. G., Venkatesh, P., Rao, N., & Baliga, M. S. (2006). Evaluation of the radioprotective effect of Liv 52 in mice. Environmental and Molecular Mutagenesis, 47(7), 490-502. https://doi.org/10.1002/em.20218
Jagetia, Ganesh C. ; Ganapathi, Narsipura G. ; Venkatesh, Ponemone ; Rao, Nageshwar ; Baliga, Manjeshwar S. / Evaluation of the radioprotective effect of Liv 52 in mice. In: Environmental and Molecular Mutagenesis. 2006 ; Vol. 47, No. 7. pp. 490-502.
@article{728b411848754c368464ddee8cc905e6,
title = "Evaluation of the radioprotective effect of Liv 52 in mice",
abstract = "Liv 52 is a mixture of botanicals that is used clinically to treat various hepatic disorders. In this study, the radioprotective activity of Liv 52 was evaluated in mice given whole-body exposure to different doses of γ-radiation. In addition, a series of studies was conducted to explore the mechanism of radioprotection. Radioprotection was evaluated by the ability of Liv 52 to reduce both the frequency of bone marrow micronucleated erythrocytes and the lethality produced by 60Co γ-radiation. Mice were treated by oral gavage once daily for seven consecutive days with 500 mg/kg body weight Liv 52 or carboxymethylcellulose vehicle prior to radiation. Micronucleated polychromatic erythrocytes (MPCEs), micronucleated normochromatic erythrocytes (MNCEs), and the PCE/NCE ratio were measured at 0.25-14 days after exposure to whole-body radiation doses of 0, 0.5, 1.5, 3.0, or 4.5 Gy; animal survival was monitored after doses of 7, 8, 9, 10, 11, or 1 2 Gy. Pretreatment of mice with Liv 52 significantly reduced the frequency of radiation-induced MPCEs and MNCEs. Irradiation reduced the PCE/NCE ratio in a dose-related manner for up to 7 days following irradiation; Liv 52 pretreatment significantly mitigated against these reductions. Liv 52 treatment also reduced the symptoms of radiation sickness and increased mouse survival 10 and 30 days after irradiation. Liv 52 pretreatment elevated the levels of reduced glutathione (GSH), increased the activities of glutathione transferase, GSH peroxidase, GSH reductase, superoxide dismutase, and catalase, and lowered lipid peroxidation (LPx) and the activities of alanine aminotransferase and aspartate aminotransferase 30 min after exposure to 7 Gy of γ-radiation. Liv 52 pretreatment also reduced radiation-induced LPx and increased GSH concentration 31 days following the exposure. The results of this study indicate that pretreatment with Liv 52 reduces the genotoxic and lethal effects of γ-irradiation in mice and suggest that this radioprotection may be afforded by reducing the toxic effects of the oxidative products of irradiation.",
author = "Jagetia, {Ganesh C.} and Ganapathi, {Narsipura G.} and Ponemone Venkatesh and Nageshwar Rao and Baliga, {Manjeshwar S.}",
year = "2006",
month = "8",
day = "1",
doi = "10.1002/em.20218",
language = "English",
volume = "47",
pages = "490--502",
journal = "Environmental Mutagenesis",
issn = "0893-6692",
publisher = "Wiley-Liss Inc.",
number = "7",

}

Jagetia, GC, Ganapathi, NG, Venkatesh, P, Rao, N & Baliga, MS 2006, 'Evaluation of the radioprotective effect of Liv 52 in mice', Environmental and Molecular Mutagenesis, vol. 47, no. 7, pp. 490-502. https://doi.org/10.1002/em.20218

Evaluation of the radioprotective effect of Liv 52 in mice. / Jagetia, Ganesh C.; Ganapathi, Narsipura G.; Venkatesh, Ponemone; Rao, Nageshwar; Baliga, Manjeshwar S.

In: Environmental and Molecular Mutagenesis, Vol. 47, No. 7, 01.08.2006, p. 490-502.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evaluation of the radioprotective effect of Liv 52 in mice

AU - Jagetia, Ganesh C.

AU - Ganapathi, Narsipura G.

AU - Venkatesh, Ponemone

AU - Rao, Nageshwar

AU - Baliga, Manjeshwar S.

PY - 2006/8/1

Y1 - 2006/8/1

N2 - Liv 52 is a mixture of botanicals that is used clinically to treat various hepatic disorders. In this study, the radioprotective activity of Liv 52 was evaluated in mice given whole-body exposure to different doses of γ-radiation. In addition, a series of studies was conducted to explore the mechanism of radioprotection. Radioprotection was evaluated by the ability of Liv 52 to reduce both the frequency of bone marrow micronucleated erythrocytes and the lethality produced by 60Co γ-radiation. Mice were treated by oral gavage once daily for seven consecutive days with 500 mg/kg body weight Liv 52 or carboxymethylcellulose vehicle prior to radiation. Micronucleated polychromatic erythrocytes (MPCEs), micronucleated normochromatic erythrocytes (MNCEs), and the PCE/NCE ratio were measured at 0.25-14 days after exposure to whole-body radiation doses of 0, 0.5, 1.5, 3.0, or 4.5 Gy; animal survival was monitored after doses of 7, 8, 9, 10, 11, or 1 2 Gy. Pretreatment of mice with Liv 52 significantly reduced the frequency of radiation-induced MPCEs and MNCEs. Irradiation reduced the PCE/NCE ratio in a dose-related manner for up to 7 days following irradiation; Liv 52 pretreatment significantly mitigated against these reductions. Liv 52 treatment also reduced the symptoms of radiation sickness and increased mouse survival 10 and 30 days after irradiation. Liv 52 pretreatment elevated the levels of reduced glutathione (GSH), increased the activities of glutathione transferase, GSH peroxidase, GSH reductase, superoxide dismutase, and catalase, and lowered lipid peroxidation (LPx) and the activities of alanine aminotransferase and aspartate aminotransferase 30 min after exposure to 7 Gy of γ-radiation. Liv 52 pretreatment also reduced radiation-induced LPx and increased GSH concentration 31 days following the exposure. The results of this study indicate that pretreatment with Liv 52 reduces the genotoxic and lethal effects of γ-irradiation in mice and suggest that this radioprotection may be afforded by reducing the toxic effects of the oxidative products of irradiation.

AB - Liv 52 is a mixture of botanicals that is used clinically to treat various hepatic disorders. In this study, the radioprotective activity of Liv 52 was evaluated in mice given whole-body exposure to different doses of γ-radiation. In addition, a series of studies was conducted to explore the mechanism of radioprotection. Radioprotection was evaluated by the ability of Liv 52 to reduce both the frequency of bone marrow micronucleated erythrocytes and the lethality produced by 60Co γ-radiation. Mice were treated by oral gavage once daily for seven consecutive days with 500 mg/kg body weight Liv 52 or carboxymethylcellulose vehicle prior to radiation. Micronucleated polychromatic erythrocytes (MPCEs), micronucleated normochromatic erythrocytes (MNCEs), and the PCE/NCE ratio were measured at 0.25-14 days after exposure to whole-body radiation doses of 0, 0.5, 1.5, 3.0, or 4.5 Gy; animal survival was monitored after doses of 7, 8, 9, 10, 11, or 1 2 Gy. Pretreatment of mice with Liv 52 significantly reduced the frequency of radiation-induced MPCEs and MNCEs. Irradiation reduced the PCE/NCE ratio in a dose-related manner for up to 7 days following irradiation; Liv 52 pretreatment significantly mitigated against these reductions. Liv 52 treatment also reduced the symptoms of radiation sickness and increased mouse survival 10 and 30 days after irradiation. Liv 52 pretreatment elevated the levels of reduced glutathione (GSH), increased the activities of glutathione transferase, GSH peroxidase, GSH reductase, superoxide dismutase, and catalase, and lowered lipid peroxidation (LPx) and the activities of alanine aminotransferase and aspartate aminotransferase 30 min after exposure to 7 Gy of γ-radiation. Liv 52 pretreatment also reduced radiation-induced LPx and increased GSH concentration 31 days following the exposure. The results of this study indicate that pretreatment with Liv 52 reduces the genotoxic and lethal effects of γ-irradiation in mice and suggest that this radioprotection may be afforded by reducing the toxic effects of the oxidative products of irradiation.

UR - http://www.scopus.com/inward/record.url?scp=33747875032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747875032&partnerID=8YFLogxK

U2 - 10.1002/em.20218

DO - 10.1002/em.20218

M3 - Article

C2 - 16758471

AN - SCOPUS:33747875032

VL - 47

SP - 490

EP - 502

JO - Environmental Mutagenesis

JF - Environmental Mutagenesis

SN - 0893-6692

IS - 7

ER -

Jagetia GC, Ganapathi NG, Venkatesh P, Rao N, Baliga MS. Evaluation of the radioprotective effect of Liv 52 in mice. Environmental and Molecular Mutagenesis. 2006 Aug 1;47(7):490-502. https://doi.org/10.1002/em.20218